Resolution‐Oriented Immunopharmacological Potential of the Lipid Matrix of Rhynchophorus palmarum Larvae in Viral Respiratory Infections: A Perspect

ABSTRACT

This review explores how the fatty acid (FA) profile of the Amazonian Rhynchophorus palmarum larva (Chontacuro), traditionally eaten for respiratory ailments, might biochemically mitigate viral respiratory infections. During metamorphosis, this insect utilizes its unique FA matrix to survive severe, self‐inflicted oxidative and inflammatory tissue stress. The authors hypothesize that when consumed by humans, these insect lipids undergo chylomicron‐mediated lymphatic transport. This pathway bypasses initial liver metabolism, delivering unsaturated FAs directly to the pulmonary microvasculature and alveolar macrophages in the lungs. Once there, the FAs are proposed to act via two main mechanisms: One is inflammation resolution, where the ω‐3 fraction is hypothesized to be metabolized via the 15‐LOX enzyme pathway into Specialized Pro‐Resolving Mediators (SPMs) and activate PPAR‐α, potentially shifting the immune response from chronic inflammation toward active tissue repair. The other is viral sabotage: The highly unsaturated fats increase cell membrane fluidity, destabilizing the “lipid rafts” that viruses rely on for cellular entry and assembly. While in vitro and in silico models suggest a synergistic “cocktail effect” that primes and then resolves the immune response, the authors note that direct human clinical evidence is currently lacking.